Takeda Pharmaceutical (TAK) Long-Term Investments (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Long-Term Investments of $63.23 million for the quarter ended Jun 30, 2026, down 8.0% from $68.74 million a year earlier but up 12.7% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Long-Term Investments (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical's Long-Term Investments came in at $58.43 million, down 17.6% from the prior year.
- Annual Long-Term Investments has declined for five consecutive years, with a five-year compound annual growth rate of -44.0% (years ended Mar 2021 to Mar 2026).
- In prior years, Takeda Pharmaceutical's Long-Term Investments was $70.91 million in the year ended Mar 31, 2025 (-88.6%), $622.9 million in the year ended Mar 31, 2024 (-15.1%), $734.11 million in the year ended Mar 31, 2023 (-14.7%) and $860.23 million in the year ended Mar 31, 2022 (-18.9%).
- Quarterly Long-Term Investments has run from a low of $56.09 million in the quarter ended Mar 31, 2026 to a high of $831.05 million in the quarter ended Mar 31, 2022 over five years.
- On a year-over-year basis, Long-Term Investments has declined in each of the last ten quarters, with an average decline of 55.2% over the last eight quarters.
- The strongest year-over-year quarter for Long-Term Investments in the past five years was the quarter ended Dec 31, 2023, with growth of 4.6%; the weakest was the quarter ended Mar 31, 2025, with a decline of 88.3%.
- According to Business Quant data, Long-Term Investments for the three prior quarters was $56.09 million (quarter ended Mar 31, 2026), $66.21 million (quarter ended Dec 31, 2025) and $60.53 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Takeda Pharmaceutical | 2.59 Bn | -23.92 Bn | 5.10 Bn | 63.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.23 Mn |
| Mar 31, 2026 | 56.09 Mn |
| Dec 31, 2025 | 66.21 Mn |
| Sep 30, 2025 | 60.53 Mn |
| Jun 30, 2025 | 68.74 Mn |
| Mar 31, 2025 | 70.80 Mn |
| Dec 31, 2024 | 83.48 Mn |
| Sep 30, 2024 | 104.77 Mn |
| Jun 30, 2024 | 563.30 Mn |
| Mar 31, 2024 | 606.16 Mn |
| Dec 31, 2023 | 698.93 Mn |
| Sep 30, 2023 | 713.99 Mn |
| Jun 30, 2023 | 732.76 Mn |
| Mar 31, 2023 | 749.75 Mn |
| Dec 31, 2022 | 668.38 Mn |
| Sep 30, 2022 | 701.41 Mn |
| Jun 30, 2022 | 750.74 Mn |
| Mar 31, 2022 | 831.05 Mn |
| Jun 30, 2021 | 1.06 Bn |
| Mar 31, 2021 | 1.06 Bn |
API Access
Takeda Pharmaceutical Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();